GB Sciences Inc logo

GB Sciences Inc

$ 0.03 +0.00175 (+6.47%) 09:58 AM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 9.48M
Enterprise V:
$ 10.06M
Volume:
3.62K
Avg Vol (2M):
169.22K
Also Trade In:
Volume:
3.62K
Market Cap $:
9.48M
PE Ratio:
At Loss
Avg Vol (2-Month):
169.22K
Enterprise Value $:
10.06M
PB Ratio:
0
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

GB Sciences Inc
NAICS : 325411 SIC : 2834
3550 W. Teco Avenue, Las vegas, NV, USA, 89118
Description
GB Sciences Inc is active in the healthcare sector. The company is engaged in developing and utilizing technologies in plant biology, cultivation, and extraction techniques combined with biotechnology, and plans to produce medical-grade cannabis, cannabis concentrates, and cannabinoid therapies. It seeks to be a technology and solution company that converts the cannabis plant into medicines, therapies, and treatments for a range of ailments.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.17
Equity-to-Asset -0.7
Debt-to-Equity -0.78
Debt-to-EBITDA 3.48
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score -5.16
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Revenue Growth Rate -100
3-Year EPS without NRI Growth Rate -100
3-Year FCF Growth Rate 50

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 53.08
9-Day RSI 51.63
14-Day RSI 51.78
6-1 Month Momentum % -39.39
12-1 Month Momentum % -50.37

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.08
Quick Ratio 0.08
Cash Ratio 0.06

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -10.5

Profitability Rank

Name Current Vs Industry Vs History
ROA % -6.56
ROIC % -19.5
ROC (Joel Greenblatt) % 1395.74
ROCE % 28.93
Years of Profitability over Past 10-Year 1

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT 32.16
EV-to-EBITDA 26.5
EV-to-FCF -4.87
Earnings Yield (Greenblatt) % 3.1

Financials

GBLX's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with OTCPK:GBLX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -0.006
Beta 0.14
Volatility % 93.79
14-Day RSI 51.78
14-Day ATR ($) 0.003814
20-Day SMA ($) 0.02768
12-1 Month Momentum % -50.37
52-Week Range ($) 0.0151 - 0.04995
Shares Outstanding (Mil) 329.2

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

GB Sciences Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More